Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 17;9(22):e018604.
doi: 10.1161/JAHA.120.018604. Epub 2020 Nov 10.

Recognizing Cardiovascular Risk After Preeclampsia: The P4 Study

Affiliations

Recognizing Cardiovascular Risk After Preeclampsia: The P4 Study

Mark A Brown et al. J Am Heart Assoc. .

Abstract

Background There is increased risk of hypertension, early cardiovascular disease, and premature mortality in women who have had preeclampsia. This study was undertaken to determine the upper limit of normal blood pressure (BP) 6 months postpartum and the frequency of women with prior preeclampsia who had BP above these limits, as part of the P4 (Post-Partum Physiology, Psychology and Pediatric) follow-up study. Methods and Results BP was measured by sphygmomanometer, 24-hour ambulatory BP monitoring, and non-invasive central BP at 6 months postpartum in 302 women who had normotensive pregnancy and 90 who had preeclampsia. The upper limit of normal BP (mean+2 SD) for women with normotensive pregnancy was 122/79 mm Hg for routine BP, 115/81 mm Hg for central BP, and 121/78 mm Hg for 24-hour ambulatory BP monitoring. Traditional normal values detected only 3% of women who had preeclampsia as having high BP 6 months postpartum whereas these new values detected between 13% and 19%. Women with preeclampsia had greater body mass index (27.8 versus 25.0, P<0.001) and left ventricular wall thickness but similar augmentation index. They also had lower high-density lipoprotein (59±15 versus 65±16 mg/dL, P=0.002), higher triglycerides (77±51 versus 61±35 mg/dL, P=0.005), and higher homeostatic model assessment score (2.1±1.8 versus 1.3±1.9, P<0.001). Conclusions Clinicians wishing to detect high BP in these women should be aware of the lower than usual upper limit of normal for this young cohort and where possible should use 24-hour ambulatory BP monitoring to detect these changes. This may define a subgroup of women who had preeclampsia for whom targeted BP lowering therapy would be successful. Registration URL: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365295&isReview=true; Unique identifier: ACTRN12613001260718.

Keywords: blood pressure monitoring; cardiovascular risk; high blood pressure; preeclampsia; pregnancy hypertension.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1. Routine sphygmomanometry and ambulatory awake, sleep, and central systolic and diastolic blood pressures and pulse pressures 6 months postpartum.
All measurements were significantly higher in women who had preeclampsia, P<0.001. DBP indicates diastolic blood pressure; PP, pulse pressure; and SBP, systolic blood pressure.
Figure 2
Figure 2. Percentage of women who have had preeclampsia with blood pressures above the normal ranges according to our new data (blue), traditional cut‐offs (red), and American College of Cardiology/American Heart Association definitions (green).
Significant difference in frequencies are indicated by P values of comparisons with percentage above new normal. All blood pressures are expressed as mm Hg. ACC/AHA indicates American College of Cardiology/American Heart Association; DBP, diastolic blood pressure; PP, pulse pressure; and SBP, systolic blood pressure.

References

    1. Leon LJ, McCarthy FP, Direk K, Gonzalez‐Izquierdo A, Prieto‐Merino D, Casas JP, Chappell L. Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records. Circulation. 2019;140:1050–1060. - PubMed
    1. Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre‐eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019;365:l1516. - PMC - PubMed
    1. Khashan AS, Evans M, Kublickas M, McCarthy FP, Kenny LC, Stenvinkel P, Fitzgerald T, Kublickiene K. Preeclampsia and risk of end stage kidney disease: a Swedish nationwide cohort study. PloS Med. 2019;16:e1002875. - PMC - PubMed
    1. Stuart JJ, Tanz LJ, Missmer SA, Rimm EB, Spiegelman D, James‐Todd TM, Rich‐Edwards JW. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018;169:224–232. - PMC - PubMed
    1. Bergen NE, Schalekamp‐Timmermans S, Roos‐Hesselink J, Roeters van Lennep JE, Jaddoe VVW, Steegers EAP. Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health. Eur J Epidemiol. 2018;33:763–771. - PMC - PubMed

Publication types

LinkOut - more resources